CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 74 enrolled
Drug / intervention
Intravenous insulin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00812253
NCT00812253Phase 2Completed
CompareCT.gov

Intensive Glycemic Control for Congestive Heart Failure Exacerbation

Kathleen Dungan·interventional·Posted Dec 22, 2008·Updated Jan 2, 2018

In Brief

A Phase 2 clinical trial evaluating Intravenous insulin and Subcutaneous insulin for Congestive Heart Failure and Diabetes Mellitus. Completed, enrolled 74 participants across 1 site.

Detailed Summary

Patients with heart failure often have high blood sugar (glucose).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCongestive Heart Failure, Diabetes Mellitus
CountriesUnited States
CollaboratorsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Timeline

Phase 2CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedDec 22, 2008
Enrollment StartJan 1, 2009
Primary CompletionSep 1, 2013
Study CompletionMay 1, 2014
TodayJul 2, 2026
Enrollment to primary: 4.7 yearsPosted 17.5 years ago

Interventions

Intravenous insulindrug

Half of subjects will receive insulin through the intravenous route while the other half will receive 4 injections per day.

Subcutaneous insulindrug

Half of subjects will receive insulin through the intravenous route while the other half will receive 4 injections per day.